Interparfums Inc header image

Interparfums Inc

IPAR

Equity

ISIN null / Valor 833467

NASDAQ (2026-05-28)
USD 96.40+1.35%

Interparfums Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Inter Parfums, Inc., established in 1982, operates within the global fragrance industry, specializing in the production and distribution of an extensive range of prestige fragrance and fragrance-related products. The company conducts its operations through two main segments: European operations, managed by its 72% owned subsidiary Interparfums SA, and United States-based operations. Inter Parfums holds license agreements with various brand owners, producing and distributing products for a portfolio of prestige brands such as Boucheron, Coach, Jimmy Choo, and Montblanc, among others. These products are available in over 120 countries. European operations account for approximately 65% of the company's net sales, with the remaining 35% generated by its U.S. operations, which include brands like Abercrombie & Fitch, Anna Sui, and Donna Karan. The company focuses on leveraging the strong market presence of these brands, introducing new fragrance families every few years alongside seasonal and limited-edition fragrances to maintain consumer interest and market relevance.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (17.05.2026):

Inter Parfums, Inc. reported results for the third quarter of 2020. Net sales were $160.6 million (down 16.0% year-over-year; down 18.3% at comparable foreign exchange), with net income attributable to Inter Parfums, Inc. of $16.5 million and diluted EPS of $0.52. Gross margin improved modestly while operating income and net income declined versus the third quarter of 2019.

Sales

Net sales: $160.6 million for Q3 2020, down 16.0% from $191.2 million in Q3 2019; on a constant-currency basis sales declined 18.3%.

Geographic performance

European-based operations: $129.7 million, down 9.6% year-over-year. U.S.-based operations: $30.9 million, down 35.1% year-over-year.

Profitability

Gross margin increased to 60.5% (from 59.8% in Q3 2019). Operating margin was 19.5% (versus 19.2% a year earlier).

Operating results and expenses

Operating income declined to $31.4 million from $36.6 million (a 14.4% decrease). Selling, general & administrative expenses were 41.0% of sales versus 40.7% in Q3 2019.

Net income and EPS

Net income attributable to Inter Parfums, Inc. was $16.5 million (down 20.7% from $20.8 million). Diluted earnings per share were $0.52, down 21.2% from $0.66.

Tax and currency

The effective income tax rate was 28.8% (versus 27.4% in Q3 2019). The average dollar/euro exchange rate for Q3 2020 was 1.17 compared with 1.11 in Q3 2019, a factor noted in the company’s reported results.

Summarized from source with an LLMView Source

Key figures

-27.7%1Y
-24.9%3Y
26.0%5Y

Performance

29.4%1Y
33.0%3Y
33.3%5Y

Volatility

Market cap

3087 M

Market cap (USD)

Daily traded volume (Shares)

178,294

Daily traded volume (Shares)

1 day high/low

130.95 / 127.9

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

RHOEN-KLINIKUM AG
RHOEN-KLINIKUM AG RHOEN-KLINIKUM AG Valor: 341644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.60%EUR 12.30
Medios AG
Medios AG Medios AG Valor: 19069483
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.19%EUR 13.60
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.69%CHF 4.47
Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.39%CHF 350.40
Medacta Group Ltd
Medacta Group Ltd Medacta Group Ltd Valor: 46852522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.43%CHF 143.20
AEVIS VICTORIA SA
AEVIS VICTORIA SA AEVIS VICTORIA SA Valor: 47863410
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 13.00
Vitrolife AB
Vitrolife AB Vitrolife AB Valor: 41707777
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.30%SEK 100.90
Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Inc Ligand Pharmaceuticals Inc Valor: 12015449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.52%USD 234.66
Draegerwerk AG & Co. KGaA
Draegerwerk AG & Co. KGaA Draegerwerk AG & Co. KGaA Valor: 330446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.08%EUR 91.80
elf Beauty Inc
elf Beauty Inc elf Beauty Inc Valor: 33775016
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 57.40